Massimo Falconi
Vita-Salute San Raffaele University
CancerInternal medicineRadiologySurgeryPathologyOncologyPancreatitisPancreatic diseasePancreatectomyPancreasPancreaticoduodenectomyNeuroendocrine tumorsDiseasePancreatic cancerPancreatic fistulaAdenocarcinomaIn patientGeneral surgeryMedicineGastroenterology
904Publications
105H-index
36.3kCitations
Publications 909
Newest
#1Stefano CrippaH-Index: 60
#2G. Belfiori (UniSR: Vita-Salute San Raffaele University)H-Index: 6
Last. Massimo FalconiH-Index: 105
view all 10 authors...
Abstract Background Current treatment of potentially resectable pancreatic ductal adenocarcinoma (PDAC) includes pancreatic resection followed by adjuvant therapy. Aim of this study is to identify factors that are related with overall and early recurrence after pancreatectomy for PDAC. Methods Retrospective analysis of patients with histologically confirmed PDAC who underwent pancreatectomy between September 2009 and December 2014. Early relapse was defined as recurrence within 12 months after s...
2 CitationsSource
#1Francesca MuffattiH-Index: 14
#2Stefano Partelli (UniSR: Vita-Salute San Raffaele University)H-Index: 43
Last. Massimo FalconiH-Index: 105
view all 4 authors...
Source
#1Giuseppe Vanella (UniSR: Vita-Salute San Raffaele University)H-Index: 8
#2Domenico TamburrinoH-Index: 16
Last. Paolo Giorgio Arcidiacono (UniSR: Vita-Salute San Raffaele University)H-Index: 40
view all 7 authors...
Source
#1Carolina Bezzi (UniSR: Vita-Salute San Raffaele University)H-Index: 1
#2Paola Mapelli (UniSR: Vita-Salute San Raffaele University)H-Index: 12
Last. Maria Picchio (UniSR: Vita-Salute San Raffaele University)H-Index: 59
view all 11 authors...
PURPOSE To present the state-of-art of radiomics in the context of pancreatic neuroendocrine tumors (PanNETs), with a focus on the methodological and technical approaches used, to support the search of guidelines for optimal applications. Furthermore, an up-to-date overview of the current clinical applications of radiomics in the field of PanNETs is provided. METHODS Original articles were searched on PubMed and Science Direct with specific keywords. Evaluations of the selected studies have been...
1 CitationsSource
#1Stefano CrippaH-Index: 60
Last. Marco Del Chiaro (Anschutz Medical Campus)H-Index: 31
view all 13 authors...
Abstract Background 2017 International and 2018 European guidelines are the most recent guidelines for intraductal papillary mucinous neoplasms management. Aim to evaluate the diagnostic accuracy of these guidelines in identifying malignant IPMN. Methods data from resected patients with IPMN were collected in two referral centers. Features of risk associated to cancerous degeneration described in International and European guidelines were retrospectively applied. Sensitivity, specificity, positi...
Source
#1Stefano PartelliH-Index: 43
#2Claudio RicciH-Index: 28
Last. Massimo FalconiH-Index: 105
view all 10 authors...
Abstract Background The cost-effectiveness of minimally invasive distal pancreatectomy (MIDP) is still a matter of debate. This study compares the cost-effectiveness of open (ODP), laparoscopic (LDP) and robotic distal pancreatectomy (RDP). Methods Pubmed, Web of Science and Cochrane Library databases were searched. Studies comparing cost-effectiveness of ODP and MIDP were included. Results A total of 1052 titles were screened and 16 articles were included in the study, 2431 patients in total. L...
Source
Source
#1Domenico Tamburrino (UniSR: Vita-Salute San Raffaele University)H-Index: 16
#2Giovanni Guarneri (UniSR: Vita-Salute San Raffaele University)H-Index: 4
Last. Massimo Falconi (UniSR: Vita-Salute San Raffaele University)H-Index: 105
view all 8 authors...
Pancreatic ductal adenocarcinoma (PDAC) is currently the fourth leading cause of cancer-related death in the USA. A wealth of evidence has demonstrated the chemopreventive activity of aspirin, statins, and metformin against PDAC. The aim of this study is to investigate the effect of aspirin, statins, and metformin on disease-free survival (DFS) and disease-specific survival (DSS) in a large population of PDAC patients undergoing pancreatic resection. All patients who underwent pancreatic resecti...
2 CitationsSource
#1Fabio Casciani (UPenn: University of Pennsylvania)H-Index: 2
#2Maxwell T. Trudeau (UPenn: University of Pennsylvania)H-Index: 3
Last. John W. KunstmanH-Index: 18
view all 55 authors...
Abstract Background Pancreatoduodenectomies at high risk for clinically relevant pancreatic fistula are uncommon, yet intimidating, situations. In such scenarios, the impact of individual surgeon experience on outcomes is poorly understood. Methods The fistula risk score was applied to identify high-risk patients (fistula risk score 7–10) from 7,706 pancreatoduodenectomies performed at 18 international institutions (2003–2020). For each case, surgeon pancreatoduodenectomy career volume and years...
3 CitationsSource
#1Domenico TamburrinoH-Index: 16
#2Giovanni GuarneriH-Index: 4
Last. Massimo Falconi (UniSR: Vita-Salute San Raffaele University)H-Index: 105
view all 4 authors...
Source